KGMTM Keratinocyte BulletKitTM, Calcium Free. (Pack of 6)
The PyroCell® MAT System, IL-6 is an all-inclusive kit to conduct the MAT assay. It combines the PyroCell® MAT Kit and the Pelikine compact human IL-6 ELISA kit. It contains 3 vials of cryopreserved, pooled PBMC (pMAT Cells), 3 vials of MAT Culture Medium Supplement, the PeliKine compact human IL-6 kit and the PeliKine tool set 1 sufficient for 288 test (3 ELISA plate).
SeaPlaque® Agarose, 25 g, is the original low melting temperature agarose.
SeaPlaque® Agarose, 125 g, is the original low melting temperature agarose.
SeaPlaque® Agarose, 500 g, is the original low melting temperature agarose.
Used in combination with the PyroCell® MAT Kit to conduct the Monocyte Activation Test (MAT). The PeliKine compact human IL-6 ELISA Kit contains all necessary reagents and buffers to perform 288 tests (3 ELISA plates).
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device SeriescGMP Cell Line Nucleofector Kit T
-
CAR-T Cells – Latest Advances and Outstanding Challenges